Global Biciruizumab Market Growth 2026-2032
The global Biciruizumab market size is predicted to grow from US$ 2464 million in 2025 to US$ 8853 million in 2032; it is expected to grow at a CAGR of 15.6% from 2026 to 2032.
Bevacizumab is a recombinant humanized monoclonal antibody primarily used for the treatment of various types of cancer, including colorectal cancer, non-small cell lung cancer, and renal cell carcinoma. It works by targeting and inhibiting the action of vascular endothelial growth factor (VEGF), preventing the formation of new blood vessels in tumors, thus reducing tumor blood supply and inhibiting tumor growth and spread. Bevacizumab is widely used in combination cancer therapies, typically in conjunction with chemotherapy or other targeted drugs to enhance therapeutic efficacy. The drug is administered intravenously and has been approved for clinical use in multiple countries and regions.In 2025, global Bimekizumab production reached approximately 1.2 million vials.
Bevacizumab holds an important position in the global cancer drug market, especially in the treatment of various solid tumors, such as colorectal cancer, non-small cell lung cancer, and renal cell carcinoma. With the continuous rise in cancer prevalence and ongoing innovations in cancer treatment, the market demand for Bevacizumab is steadily increasing. This drug works by inhibiting vascular endothelial growth factor (VEGF), blocking tumor angiogenesis, and significantly improving treatment outcomes, particularly when used in combination with chemotherapy and other targeted therapies. The market prospects for Bevacizumab are very promising, particularly in developing countries and emerging markets, where improvements in healthcare infrastructure and the widespread adoption of cancer screening will benefit more patients. Although Bevacizumab is priced relatively high and faces competition from generic drugs, it remains a core component of many cancer treatment regimens. Additionally, as research into Bevacizumab?s use in other cancer types continues to expand, it is expected that the drug?s indications will continue to grow, further driving market growth.
LP Information, Inc. (LPI) ' newest research report, the ?Biciruizumab Industry Forecast? looks at past sales and reviews total world Biciruizumab sales in 2025, providing a comprehensive analysis by region and market sector of projected Biciruizumab sales for 2026 through 2032. With Biciruizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biciruizumab industry.
This Insight Report provides a comprehensive analysis of the global Biciruizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biciruizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Biciruizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biciruizumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biciruizumab.
This report presents a comprehensive overview, market shares, and growth opportunities of Biciruizumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Biciruizumab market?
What factors are driving Biciruizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biciruizumab market opportunities vary by end market size?
How does Biciruizumab break out by Type, by Application?
Bevacizumab is a recombinant humanized monoclonal antibody primarily used for the treatment of various types of cancer, including colorectal cancer, non-small cell lung cancer, and renal cell carcinoma. It works by targeting and inhibiting the action of vascular endothelial growth factor (VEGF), preventing the formation of new blood vessels in tumors, thus reducing tumor blood supply and inhibiting tumor growth and spread. Bevacizumab is widely used in combination cancer therapies, typically in conjunction with chemotherapy or other targeted drugs to enhance therapeutic efficacy. The drug is administered intravenously and has been approved for clinical use in multiple countries and regions.In 2025, global Bimekizumab production reached approximately 1.2 million vials.
Bevacizumab holds an important position in the global cancer drug market, especially in the treatment of various solid tumors, such as colorectal cancer, non-small cell lung cancer, and renal cell carcinoma. With the continuous rise in cancer prevalence and ongoing innovations in cancer treatment, the market demand for Bevacizumab is steadily increasing. This drug works by inhibiting vascular endothelial growth factor (VEGF), blocking tumor angiogenesis, and significantly improving treatment outcomes, particularly when used in combination with chemotherapy and other targeted therapies. The market prospects for Bevacizumab are very promising, particularly in developing countries and emerging markets, where improvements in healthcare infrastructure and the widespread adoption of cancer screening will benefit more patients. Although Bevacizumab is priced relatively high and faces competition from generic drugs, it remains a core component of many cancer treatment regimens. Additionally, as research into Bevacizumab?s use in other cancer types continues to expand, it is expected that the drug?s indications will continue to grow, further driving market growth.
LP Information, Inc. (LPI) ' newest research report, the ?Biciruizumab Industry Forecast? looks at past sales and reviews total world Biciruizumab sales in 2025, providing a comprehensive analysis by region and market sector of projected Biciruizumab sales for 2026 through 2032. With Biciruizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biciruizumab industry.
This Insight Report provides a comprehensive analysis of the global Biciruizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biciruizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Biciruizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biciruizumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biciruizumab.
This report presents a comprehensive overview, market shares, and growth opportunities of Biciruizumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 100 mg/4 mL
- 320 mg/2 mL
- Bimekizumab In Combination With Methotrexate
- Bimekizumab Combined With Topical Corticosteroids
- Hospital
- Retail
- Online
- Intravenous Injection
- Subcutaneous Injection
- Psoriasis
- Ankylosing Spondylitis
- Hidradenitis Suppurativa
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Chugai Pharmaceutical
- Amgen
- Pfizer
- Qilu Pharmaceutical
- Innovent Biologics
- Jiangsu Hengrui Medicine
- Shandong Boan Biotechnology
What is the 10-year outlook for the global Biciruizumab market?
What factors are driving Biciruizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biciruizumab market opportunities vary by end market size?
How does Biciruizumab break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biciruizumab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Biciruizumab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Biciruizumab by Country/Region, 2021, 2025 & 2032
2.2 Biciruizumab Segment by Type
2.2.1 100 mg/4 mL
2.2.2 320 mg/2 mL
2.2.3 Biciruizumab Sales by Type
2.2.3.1 Global Biciruizumab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Biciruizumab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Biciruizumab Sale Price by Type (2021-2026)
2.3 Biciruizumab Segment by Specification
2.3.1 Bimekizumab In Combination With Methotrexate
2.3.2 Bimekizumab Combined With Topical Corticosteroids
2.3.3 Biciruizumab Sales by Specification
2.3.3.1 Global Biciruizumab Sales Market Share by Specification (2021-2026)
2.3.3.2 Global Biciruizumab Revenue and Market Share by Specification (2021-2026)
2.3.3.3 Global Biciruizumab Sale Price by Specification (2021-2026)
2.4 Biciruizumab Segment by Sales Channels
2.4.1 Hospital
2.4.2 Retail
2.4.3 Online
2.4.4 Biciruizumab Sales by Sales Channels
2.4.4.1 Global Biciruizumab Sales Market Share by Sales Channels (2021-2026)
2.4.4.2 Global Biciruizumab Revenue and Market Share by Sales Channels (2021-2026)
2.4.4.3 Global Biciruizumab Sale Price by Sales Channels (2021-2026)
2.5 Biciruizumab Segment by Dosage Form
2.5.1 Intravenous Injection
2.5.2 Subcutaneous Injection
2.5.3 Biciruizumab Sales by Dosage Form
2.5.3.1 Global Biciruizumab Sales Market Share by Dosage Form (2021-2026)
2.5.3.2 Global Biciruizumab Revenue and Market Share by Dosage Form (2021-2026)
2.5.3.3 Global Biciruizumab Sale Price by Dosage Form (2021-2026)
2.6 Biciruizumab Segment by Application
2.6.1 Psoriasis
2.6.2 Ankylosing Spondylitis
2.6.3 Hidradenitis Suppurativa
2.6.4 Others
2.6.5 Biciruizumab Sales by Application
2.6.5.1 Global Biciruizumab Sale Market Share by Application (2021-2026)
2.6.5.2 Global Biciruizumab Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global Biciruizumab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Biciruizumab Breakdown Data by Company
3.1.1 Global Biciruizumab Annual Sales by Company (2021-2026)
3.1.2 Global Biciruizumab Sales Market Share by Company (2021-2026)
3.2 Global Biciruizumab Annual Revenue by Company (2021-2026)
3.2.1 Global Biciruizumab Revenue by Company (2021-2026)
3.2.2 Global Biciruizumab Revenue Market Share by Company (2021-2026)
3.3 Global Biciruizumab Sale Price by Company
3.4 Key Manufacturers Biciruizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biciruizumab Product Location Distribution
3.4.2 Players Biciruizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BICIRUIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Biciruizumab Market Size by Geographic Region (2021-2026)
4.1.1 Global Biciruizumab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Biciruizumab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Biciruizumab Market Size by Country/Region (2021-2026)
4.2.1 Global Biciruizumab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Biciruizumab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biciruizumab Sales Growth
4.4 APAC Biciruizumab Sales Growth
4.5 Europe Biciruizumab Sales Growth
4.6 Middle East & Africa Biciruizumab Sales Growth
5 AMERICAS
5.1 Americas Biciruizumab Sales by Country
5.1.1 Americas Biciruizumab Sales by Country (2021-2026)
5.1.2 Americas Biciruizumab Revenue by Country (2021-2026)
5.2 Americas Biciruizumab Sales by Type (2021-2026)
5.3 Americas Biciruizumab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biciruizumab Sales by Region
6.1.1 APAC Biciruizumab Sales by Region (2021-2026)
6.1.2 APAC Biciruizumab Revenue by Region (2021-2026)
6.2 APAC Biciruizumab Sales by Type (2021-2026)
6.3 APAC Biciruizumab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biciruizumab by Country
7.1.1 Europe Biciruizumab Sales by Country (2021-2026)
7.1.2 Europe Biciruizumab Revenue by Country (2021-2026)
7.2 Europe Biciruizumab Sales by Type (2021-2026)
7.3 Europe Biciruizumab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biciruizumab by Country
8.1.1 Middle East & Africa Biciruizumab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Biciruizumab Revenue by Country (2021-2026)
8.2 Middle East & Africa Biciruizumab Sales by Type (2021-2026)
8.3 Middle East & Africa Biciruizumab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biciruizumab
10.3 Manufacturing Process Analysis of Biciruizumab
10.4 Industry Chain Structure of Biciruizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biciruizumab Distributors
11.3 Biciruizumab Customer
12 WORLD FORECAST REVIEW FOR BICIRUIZUMAB BY GEOGRAPHIC REGION
12.1 Global Biciruizumab Market Size Forecast by Region
12.1.1 Global Biciruizumab Forecast by Region (2027-2032)
12.1.2 Global Biciruizumab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Biciruizumab Forecast by Type (2027-2032)
12.7 Global Biciruizumab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Biciruizumab Product Portfolios and Specifications
13.1.3 Roche Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Chugai Pharmaceutical
13.2.1 Chugai Pharmaceutical Company Information
13.2.2 Chugai Pharmaceutical Biciruizumab Product Portfolios and Specifications
13.2.3 Chugai Pharmaceutical Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Chugai Pharmaceutical Main Business Overview
13.2.5 Chugai Pharmaceutical Latest Developments
13.3 Amgen
13.3.1 Amgen Company Information
13.3.2 Amgen Biciruizumab Product Portfolios and Specifications
13.3.3 Amgen Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Amgen Main Business Overview
13.3.5 Amgen Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Biciruizumab Product Portfolios and Specifications
13.4.3 Pfizer Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Qilu Pharmaceutical
13.5.1 Qilu Pharmaceutical Company Information
13.5.2 Qilu Pharmaceutical Biciruizumab Product Portfolios and Specifications
13.5.3 Qilu Pharmaceutical Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Qilu Pharmaceutical Main Business Overview
13.5.5 Qilu Pharmaceutical Latest Developments
13.6 Innovent Biologics
13.6.1 Innovent Biologics Company Information
13.6.2 Innovent Biologics Biciruizumab Product Portfolios and Specifications
13.6.3 Innovent Biologics Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Innovent Biologics Main Business Overview
13.6.5 Innovent Biologics Latest Developments
13.7 Jiangsu Hengrui Medicine
13.7.1 Jiangsu Hengrui Medicine Company Information
13.7.2 Jiangsu Hengrui Medicine Biciruizumab Product Portfolios and Specifications
13.7.3 Jiangsu Hengrui Medicine Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jiangsu Hengrui Medicine Main Business Overview
13.7.5 Jiangsu Hengrui Medicine Latest Developments
13.8 Shandong Boan Biotechnology
13.8.1 Shandong Boan Biotechnology Company Information
13.8.2 Shandong Boan Biotechnology Biciruizumab Product Portfolios and Specifications
13.8.3 Shandong Boan Biotechnology Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shandong Boan Biotechnology Main Business Overview
13.8.5 Shandong Boan Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biciruizumab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Biciruizumab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Biciruizumab by Country/Region, 2021, 2025 & 2032
2.2 Biciruizumab Segment by Type
2.2.1 100 mg/4 mL
2.2.2 320 mg/2 mL
2.2.3 Biciruizumab Sales by Type
2.2.3.1 Global Biciruizumab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Biciruizumab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Biciruizumab Sale Price by Type (2021-2026)
2.3 Biciruizumab Segment by Specification
2.3.1 Bimekizumab In Combination With Methotrexate
2.3.2 Bimekizumab Combined With Topical Corticosteroids
2.3.3 Biciruizumab Sales by Specification
2.3.3.1 Global Biciruizumab Sales Market Share by Specification (2021-2026)
2.3.3.2 Global Biciruizumab Revenue and Market Share by Specification (2021-2026)
2.3.3.3 Global Biciruizumab Sale Price by Specification (2021-2026)
2.4 Biciruizumab Segment by Sales Channels
2.4.1 Hospital
2.4.2 Retail
2.4.3 Online
2.4.4 Biciruizumab Sales by Sales Channels
2.4.4.1 Global Biciruizumab Sales Market Share by Sales Channels (2021-2026)
2.4.4.2 Global Biciruizumab Revenue and Market Share by Sales Channels (2021-2026)
2.4.4.3 Global Biciruizumab Sale Price by Sales Channels (2021-2026)
2.5 Biciruizumab Segment by Dosage Form
2.5.1 Intravenous Injection
2.5.2 Subcutaneous Injection
2.5.3 Biciruizumab Sales by Dosage Form
2.5.3.1 Global Biciruizumab Sales Market Share by Dosage Form (2021-2026)
2.5.3.2 Global Biciruizumab Revenue and Market Share by Dosage Form (2021-2026)
2.5.3.3 Global Biciruizumab Sale Price by Dosage Form (2021-2026)
2.6 Biciruizumab Segment by Application
2.6.1 Psoriasis
2.6.2 Ankylosing Spondylitis
2.6.3 Hidradenitis Suppurativa
2.6.4 Others
2.6.5 Biciruizumab Sales by Application
2.6.5.1 Global Biciruizumab Sale Market Share by Application (2021-2026)
2.6.5.2 Global Biciruizumab Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global Biciruizumab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Biciruizumab Breakdown Data by Company
3.1.1 Global Biciruizumab Annual Sales by Company (2021-2026)
3.1.2 Global Biciruizumab Sales Market Share by Company (2021-2026)
3.2 Global Biciruizumab Annual Revenue by Company (2021-2026)
3.2.1 Global Biciruizumab Revenue by Company (2021-2026)
3.2.2 Global Biciruizumab Revenue Market Share by Company (2021-2026)
3.3 Global Biciruizumab Sale Price by Company
3.4 Key Manufacturers Biciruizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biciruizumab Product Location Distribution
3.4.2 Players Biciruizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BICIRUIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Biciruizumab Market Size by Geographic Region (2021-2026)
4.1.1 Global Biciruizumab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Biciruizumab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Biciruizumab Market Size by Country/Region (2021-2026)
4.2.1 Global Biciruizumab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Biciruizumab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biciruizumab Sales Growth
4.4 APAC Biciruizumab Sales Growth
4.5 Europe Biciruizumab Sales Growth
4.6 Middle East & Africa Biciruizumab Sales Growth
5 AMERICAS
5.1 Americas Biciruizumab Sales by Country
5.1.1 Americas Biciruizumab Sales by Country (2021-2026)
5.1.2 Americas Biciruizumab Revenue by Country (2021-2026)
5.2 Americas Biciruizumab Sales by Type (2021-2026)
5.3 Americas Biciruizumab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biciruizumab Sales by Region
6.1.1 APAC Biciruizumab Sales by Region (2021-2026)
6.1.2 APAC Biciruizumab Revenue by Region (2021-2026)
6.2 APAC Biciruizumab Sales by Type (2021-2026)
6.3 APAC Biciruizumab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biciruizumab by Country
7.1.1 Europe Biciruizumab Sales by Country (2021-2026)
7.1.2 Europe Biciruizumab Revenue by Country (2021-2026)
7.2 Europe Biciruizumab Sales by Type (2021-2026)
7.3 Europe Biciruizumab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biciruizumab by Country
8.1.1 Middle East & Africa Biciruizumab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Biciruizumab Revenue by Country (2021-2026)
8.2 Middle East & Africa Biciruizumab Sales by Type (2021-2026)
8.3 Middle East & Africa Biciruizumab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biciruizumab
10.3 Manufacturing Process Analysis of Biciruizumab
10.4 Industry Chain Structure of Biciruizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biciruizumab Distributors
11.3 Biciruizumab Customer
12 WORLD FORECAST REVIEW FOR BICIRUIZUMAB BY GEOGRAPHIC REGION
12.1 Global Biciruizumab Market Size Forecast by Region
12.1.1 Global Biciruizumab Forecast by Region (2027-2032)
12.1.2 Global Biciruizumab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Biciruizumab Forecast by Type (2027-2032)
12.7 Global Biciruizumab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Biciruizumab Product Portfolios and Specifications
13.1.3 Roche Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Chugai Pharmaceutical
13.2.1 Chugai Pharmaceutical Company Information
13.2.2 Chugai Pharmaceutical Biciruizumab Product Portfolios and Specifications
13.2.3 Chugai Pharmaceutical Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Chugai Pharmaceutical Main Business Overview
13.2.5 Chugai Pharmaceutical Latest Developments
13.3 Amgen
13.3.1 Amgen Company Information
13.3.2 Amgen Biciruizumab Product Portfolios and Specifications
13.3.3 Amgen Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Amgen Main Business Overview
13.3.5 Amgen Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Biciruizumab Product Portfolios and Specifications
13.4.3 Pfizer Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Qilu Pharmaceutical
13.5.1 Qilu Pharmaceutical Company Information
13.5.2 Qilu Pharmaceutical Biciruizumab Product Portfolios and Specifications
13.5.3 Qilu Pharmaceutical Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Qilu Pharmaceutical Main Business Overview
13.5.5 Qilu Pharmaceutical Latest Developments
13.6 Innovent Biologics
13.6.1 Innovent Biologics Company Information
13.6.2 Innovent Biologics Biciruizumab Product Portfolios and Specifications
13.6.3 Innovent Biologics Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Innovent Biologics Main Business Overview
13.6.5 Innovent Biologics Latest Developments
13.7 Jiangsu Hengrui Medicine
13.7.1 Jiangsu Hengrui Medicine Company Information
13.7.2 Jiangsu Hengrui Medicine Biciruizumab Product Portfolios and Specifications
13.7.3 Jiangsu Hengrui Medicine Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jiangsu Hengrui Medicine Main Business Overview
13.7.5 Jiangsu Hengrui Medicine Latest Developments
13.8 Shandong Boan Biotechnology
13.8.1 Shandong Boan Biotechnology Company Information
13.8.2 Shandong Boan Biotechnology Biciruizumab Product Portfolios and Specifications
13.8.3 Shandong Boan Biotechnology Biciruizumab Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shandong Boan Biotechnology Main Business Overview
13.8.5 Shandong Boan Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biciruizumab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Biciruizumab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100 mg/4 mL
Table 4. Major Players of 320 mg/2 mL
Table 5. Global Biciruizumab Sales by Type (2021-2026) & (Units)
Table 6. Global Biciruizumab Sales Market Share by Type (2021-2026)
Table 7. Global Biciruizumab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Biciruizumab Revenue Market Share by Type (2021-2026)
Table 9. Global Biciruizumab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Bimekizumab In Combination With Methotrexate
Table 11. Major Players of Bimekizumab Combined With Topical Corticosteroids
Table 12. Global Biciruizumab Sales by Specification (2021-2026) & (Units)
Table 13. Global Biciruizumab Sales Market Share by Specification (2021-2026)
Table 14. Global Biciruizumab Revenue by Specification (2021-2026) & ($ million)
Table 15. Global Biciruizumab Revenue Market Share by Specification (2021-2026)
Table 16. Global Biciruizumab Sale Price by Specification (2021-2026) & (US$/Unit)
Table 17. Major Players of Hospital
Table 18. Major Players of Retail
Table 19. Major Players of Online
Table 20. Global Biciruizumab Sales by Sales Channels (2021-2026) & (Units)
Table 21. Global Biciruizumab Sales Market Share by Sales Channels (2021-2026)
Table 22. Global Biciruizumab Revenue by Sales Channels (2021-2026) & ($ million)
Table 23. Global Biciruizumab Revenue Market Share by Sales Channels (2021-2026)
Table 24. Global Biciruizumab Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 25. Major Players of Intravenous Injection
Table 26. Major Players of Subcutaneous Injection
Table 27. Global Biciruizumab Sales by Dosage Form (2021-2026) & (Units)
Table 28. Global Biciruizumab Sales Market Share by Dosage Form (2021-2026)
Table 29. Global Biciruizumab Revenue by Dosage Form (2021-2026) & ($ million)
Table 30. Global Biciruizumab Revenue Market Share by Dosage Form (2021-2026)
Table 31. Global Biciruizumab Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 32. Global Biciruizumab Sale by Application (2021-2026) & (Units)
Table 33. Global Biciruizumab Sale Market Share by Application (2021-2026)
Table 34. Global Biciruizumab Revenue by Application (2021-2026) & ($ million)
Table 35. Global Biciruizumab Revenue Market Share by Application (2021-2026)
Table 36. Global Biciruizumab Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Biciruizumab Sales by Company (2021-2026) & (Units)
Table 38. Global Biciruizumab Sales Market Share by Company (2021-2026)
Table 39. Global Biciruizumab Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Biciruizumab Revenue Market Share by Company (2021-2026)
Table 41. Global Biciruizumab Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Biciruizumab Producing Area Distribution and Sales Area
Table 43. Players Biciruizumab Products Offered
Table 44. Biciruizumab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Biciruizumab Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Biciruizumab Sales Market Share Geographic Region (2021-2026)
Table 49. Global Biciruizumab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Biciruizumab Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Biciruizumab Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Biciruizumab Sales Market Share by Country/Region (2021-2026)
Table 53. Global Biciruizumab Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Biciruizumab Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Biciruizumab Sales by Country (2021-2026) & (Units)
Table 56. Americas Biciruizumab Sales Market Share by Country (2021-2026)
Table 57. Americas Biciruizumab Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Biciruizumab Sales by Type (2021-2026) & (Units)
Table 59. Americas Biciruizumab Sales by Application (2021-2026) & (Units)
Table 60. APAC Biciruizumab Sales by Region (2021-2026) & (Units)
Table 61. APAC Biciruizumab Sales Market Share by Region (2021-2026)
Table 62. APAC Biciruizumab Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Biciruizumab Sales by Type (2021-2026) & (Units)
Table 64. APAC Biciruizumab Sales by Application (2021-2026) & (Units)
Table 65. Europe Biciruizumab Sales by Country (2021-2026) & (Units)
Table 66. Europe Biciruizumab Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Biciruizumab Sales by Type (2021-2026) & (Units)
Table 68. Europe Biciruizumab Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Biciruizumab Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Biciruizumab Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Biciruizumab Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Biciruizumab Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Biciruizumab
Table 74. Key Market Challenges & Risks of Biciruizumab
Table 75. Key Industry Trends of Biciruizumab
Table 76. Biciruizumab Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Biciruizumab Distributors List
Table 79. Biciruizumab Customer List
Table 80. Global Biciruizumab Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Biciruizumab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Biciruizumab Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Biciruizumab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Biciruizumab Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Biciruizumab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Biciruizumab Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Biciruizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Biciruizumab Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Biciruizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Biciruizumab Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Biciruizumab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Biciruizumab Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Biciruizumab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Roche Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 95. Roche Biciruizumab Product Portfolios and Specifications
Table 96. Roche Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Roche Main Business
Table 98. Roche Latest Developments
Table 99. Chugai Pharmaceutical Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 100. Chugai Pharmaceutical Biciruizumab Product Portfolios and Specifications
Table 101. Chugai Pharmaceutical Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Chugai Pharmaceutical Main Business
Table 103. Chugai Pharmaceutical Latest Developments
Table 104. Amgen Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 105. Amgen Biciruizumab Product Portfolios and Specifications
Table 106. Amgen Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Amgen Main Business
Table 108. Amgen Latest Developments
Table 109. Pfizer Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 110. Pfizer Biciruizumab Product Portfolios and Specifications
Table 111. Pfizer Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Pfizer Main Business
Table 113. Pfizer Latest Developments
Table 114. Qilu Pharmaceutical Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 115. Qilu Pharmaceutical Biciruizumab Product Portfolios and Specifications
Table 116. Qilu Pharmaceutical Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Qilu Pharmaceutical Main Business
Table 118. Qilu Pharmaceutical Latest Developments
Table 119. Innovent Biologics Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 120. Innovent Biologics Biciruizumab Product Portfolios and Specifications
Table 121. Innovent Biologics Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Innovent Biologics Main Business
Table 123. Innovent Biologics Latest Developments
Table 124. Jiangsu Hengrui Medicine Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 125. Jiangsu Hengrui Medicine Biciruizumab Product Portfolios and Specifications
Table 126. Jiangsu Hengrui Medicine Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Jiangsu Hengrui Medicine Main Business
Table 128. Jiangsu Hengrui Medicine Latest Developments
Table 129. Shandong Boan Biotechnology Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 130. Shandong Boan Biotechnology Biciruizumab Product Portfolios and Specifications
Table 131. Shandong Boan Biotechnology Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Shandong Boan Biotechnology Main Business
Table 133. Shandong Boan Biotechnology Latest Developments
Table 1. Biciruizumab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Biciruizumab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100 mg/4 mL
Table 4. Major Players of 320 mg/2 mL
Table 5. Global Biciruizumab Sales by Type (2021-2026) & (Units)
Table 6. Global Biciruizumab Sales Market Share by Type (2021-2026)
Table 7. Global Biciruizumab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Biciruizumab Revenue Market Share by Type (2021-2026)
Table 9. Global Biciruizumab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Bimekizumab In Combination With Methotrexate
Table 11. Major Players of Bimekizumab Combined With Topical Corticosteroids
Table 12. Global Biciruizumab Sales by Specification (2021-2026) & (Units)
Table 13. Global Biciruizumab Sales Market Share by Specification (2021-2026)
Table 14. Global Biciruizumab Revenue by Specification (2021-2026) & ($ million)
Table 15. Global Biciruizumab Revenue Market Share by Specification (2021-2026)
Table 16. Global Biciruizumab Sale Price by Specification (2021-2026) & (US$/Unit)
Table 17. Major Players of Hospital
Table 18. Major Players of Retail
Table 19. Major Players of Online
Table 20. Global Biciruizumab Sales by Sales Channels (2021-2026) & (Units)
Table 21. Global Biciruizumab Sales Market Share by Sales Channels (2021-2026)
Table 22. Global Biciruizumab Revenue by Sales Channels (2021-2026) & ($ million)
Table 23. Global Biciruizumab Revenue Market Share by Sales Channels (2021-2026)
Table 24. Global Biciruizumab Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 25. Major Players of Intravenous Injection
Table 26. Major Players of Subcutaneous Injection
Table 27. Global Biciruizumab Sales by Dosage Form (2021-2026) & (Units)
Table 28. Global Biciruizumab Sales Market Share by Dosage Form (2021-2026)
Table 29. Global Biciruizumab Revenue by Dosage Form (2021-2026) & ($ million)
Table 30. Global Biciruizumab Revenue Market Share by Dosage Form (2021-2026)
Table 31. Global Biciruizumab Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 32. Global Biciruizumab Sale by Application (2021-2026) & (Units)
Table 33. Global Biciruizumab Sale Market Share by Application (2021-2026)
Table 34. Global Biciruizumab Revenue by Application (2021-2026) & ($ million)
Table 35. Global Biciruizumab Revenue Market Share by Application (2021-2026)
Table 36. Global Biciruizumab Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Biciruizumab Sales by Company (2021-2026) & (Units)
Table 38. Global Biciruizumab Sales Market Share by Company (2021-2026)
Table 39. Global Biciruizumab Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Biciruizumab Revenue Market Share by Company (2021-2026)
Table 41. Global Biciruizumab Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Biciruizumab Producing Area Distribution and Sales Area
Table 43. Players Biciruizumab Products Offered
Table 44. Biciruizumab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Biciruizumab Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Biciruizumab Sales Market Share Geographic Region (2021-2026)
Table 49. Global Biciruizumab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Biciruizumab Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Biciruizumab Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Biciruizumab Sales Market Share by Country/Region (2021-2026)
Table 53. Global Biciruizumab Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Biciruizumab Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Biciruizumab Sales by Country (2021-2026) & (Units)
Table 56. Americas Biciruizumab Sales Market Share by Country (2021-2026)
Table 57. Americas Biciruizumab Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Biciruizumab Sales by Type (2021-2026) & (Units)
Table 59. Americas Biciruizumab Sales by Application (2021-2026) & (Units)
Table 60. APAC Biciruizumab Sales by Region (2021-2026) & (Units)
Table 61. APAC Biciruizumab Sales Market Share by Region (2021-2026)
Table 62. APAC Biciruizumab Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Biciruizumab Sales by Type (2021-2026) & (Units)
Table 64. APAC Biciruizumab Sales by Application (2021-2026) & (Units)
Table 65. Europe Biciruizumab Sales by Country (2021-2026) & (Units)
Table 66. Europe Biciruizumab Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Biciruizumab Sales by Type (2021-2026) & (Units)
Table 68. Europe Biciruizumab Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Biciruizumab Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Biciruizumab Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Biciruizumab Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Biciruizumab Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Biciruizumab
Table 74. Key Market Challenges & Risks of Biciruizumab
Table 75. Key Industry Trends of Biciruizumab
Table 76. Biciruizumab Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Biciruizumab Distributors List
Table 79. Biciruizumab Customer List
Table 80. Global Biciruizumab Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Biciruizumab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Biciruizumab Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Biciruizumab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Biciruizumab Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Biciruizumab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Biciruizumab Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Biciruizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Biciruizumab Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Biciruizumab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Biciruizumab Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Biciruizumab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Biciruizumab Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Biciruizumab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Roche Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 95. Roche Biciruizumab Product Portfolios and Specifications
Table 96. Roche Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Roche Main Business
Table 98. Roche Latest Developments
Table 99. Chugai Pharmaceutical Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 100. Chugai Pharmaceutical Biciruizumab Product Portfolios and Specifications
Table 101. Chugai Pharmaceutical Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Chugai Pharmaceutical Main Business
Table 103. Chugai Pharmaceutical Latest Developments
Table 104. Amgen Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 105. Amgen Biciruizumab Product Portfolios and Specifications
Table 106. Amgen Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Amgen Main Business
Table 108. Amgen Latest Developments
Table 109. Pfizer Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 110. Pfizer Biciruizumab Product Portfolios and Specifications
Table 111. Pfizer Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Pfizer Main Business
Table 113. Pfizer Latest Developments
Table 114. Qilu Pharmaceutical Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 115. Qilu Pharmaceutical Biciruizumab Product Portfolios and Specifications
Table 116. Qilu Pharmaceutical Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Qilu Pharmaceutical Main Business
Table 118. Qilu Pharmaceutical Latest Developments
Table 119. Innovent Biologics Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 120. Innovent Biologics Biciruizumab Product Portfolios and Specifications
Table 121. Innovent Biologics Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Innovent Biologics Main Business
Table 123. Innovent Biologics Latest Developments
Table 124. Jiangsu Hengrui Medicine Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 125. Jiangsu Hengrui Medicine Biciruizumab Product Portfolios and Specifications
Table 126. Jiangsu Hengrui Medicine Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Jiangsu Hengrui Medicine Main Business
Table 128. Jiangsu Hengrui Medicine Latest Developments
Table 129. Shandong Boan Biotechnology Basic Information, Biciruizumab Manufacturing Base, Sales Area and Its Competitors
Table 130. Shandong Boan Biotechnology Biciruizumab Product Portfolios and Specifications
Table 131. Shandong Boan Biotechnology Biciruizumab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Shandong Boan Biotechnology Main Business
Table 133. Shandong Boan Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biciruizumab
Figure 2. Biciruizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biciruizumab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Biciruizumab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Biciruizumab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Biciruizumab Sales Market Share by Country/Region (2025)
Figure 10. Biciruizumab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100 mg/4 mL
Figure 12. Product Picture of 320 mg/2 mL
Figure 13. Global Biciruizumab Sales Market Share by Type in 2026
Figure 14. Global Biciruizumab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Bimekizumab In Combination With Methotrexate
Figure 16. Product Picture of Bimekizumab Combined With Topical Corticosteroids
Figure 17. Global Biciruizumab Sales Market Share by Specification in 2026
Figure 18. Global Biciruizumab Revenue Market Share by Specification (2021-2026)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Retail
Figure 21. Product Picture of Online
Figure 22. Global Biciruizumab Sales Market Share by Sales Channels in 2026
Figure 23. Global Biciruizumab Revenue Market Share by Sales Channels (2021-2026)
Figure 24. Product Picture of Intravenous Injection
Figure 25. Product Picture of Subcutaneous Injection
Figure 26. Global Biciruizumab Sales Market Share by Dosage Form in 2026
Figure 27. Global Biciruizumab Revenue Market Share by Dosage Form (2021-2026)
Figure 28. Biciruizumab Consumed in Psoriasis
Figure 29. Global Biciruizumab Market: Psoriasis (2021-2026) & (Units)
Figure 30. Biciruizumab Consumed in Ankylosing Spondylitis
Figure 31. Global Biciruizumab Market: Ankylosing Spondylitis (2021-2026) & (Units)
Figure 32. Biciruizumab Consumed in Hidradenitis Suppurativa
Figure 33. Global Biciruizumab Market: Hidradenitis Suppurativa (2021-2026) & (Units)
Figure 34. Biciruizumab Consumed in Others
Figure 35. Global Biciruizumab Market: Others (2021-2026) & (Units)
Figure 36. Global Biciruizumab Sale Market Share by Application (2025)
Figure 37. Global Biciruizumab Revenue Market Share by Application in 2025
Figure 38. Biciruizumab Sales by Company in 2025 (Units)
Figure 39. Global Biciruizumab Sales Market Share by Company in 2025
Figure 40. Biciruizumab Revenue by Company in 2025 ($ millions)
Figure 41. Global Biciruizumab Revenue Market Share by Company in 2025
Figure 42. Global Biciruizumab Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Biciruizumab Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Biciruizumab Sales 2021-2026 (Units)
Figure 45. Americas Biciruizumab Revenue 2021-2026 ($ millions)
Figure 46. APAC Biciruizumab Sales 2021-2026 (Units)
Figure 47. APAC Biciruizumab Revenue 2021-2026 ($ millions)
Figure 48. Europe Biciruizumab Sales 2021-2026 (Units)
Figure 49. Europe Biciruizumab Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Biciruizumab Sales 2021-2026 (Units)
Figure 51. Middle East & Africa Biciruizumab Revenue 2021-2026 ($ millions)
Figure 52. Americas Biciruizumab Sales Market Share by Country in 2025
Figure 53. Americas Biciruizumab Revenue Market Share by Country (2021-2026)
Figure 54. Americas Biciruizumab Sales Market Share by Type (2021-2026)
Figure 55. Americas Biciruizumab Sales Market Share by Application (2021-2026)
Figure 56. United States Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Biciruizumab Sales Market Share by Region in 2025
Figure 61. APAC Biciruizumab Revenue Market Share by Region (2021-2026)
Figure 62. APAC Biciruizumab Sales Market Share by Type (2021-2026)
Figure 63. APAC Biciruizumab Sales Market Share by Application (2021-2026)
Figure 64. China Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 68. India Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Biciruizumab Sales Market Share by Country in 2025
Figure 72. Europe Biciruizumab Revenue Market Share by Country (2021-2026)
Figure 73. Europe Biciruizumab Sales Market Share by Type (2021-2026)
Figure 74. Europe Biciruizumab Sales Market Share by Application (2021-2026)
Figure 75. Germany Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 76. France Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Biciruizumab Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Biciruizumab Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Biciruizumab Sales Market Share by Application (2021-2026)
Figure 83. Egypt Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Biciruizumab in 2026
Figure 89. Manufacturing Process Analysis of Biciruizumab
Figure 90. Industry Chain Structure of Biciruizumab
Figure 91. Channels of Distribution
Figure 92. Global Biciruizumab Sales Market Forecast by Region (2027-2032)
Figure 93. Global Biciruizumab Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Biciruizumab Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Biciruizumab Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Biciruizumab Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Biciruizumab Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Biciruizumab
Figure 2. Biciruizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biciruizumab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Biciruizumab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Biciruizumab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Biciruizumab Sales Market Share by Country/Region (2025)
Figure 10. Biciruizumab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100 mg/4 mL
Figure 12. Product Picture of 320 mg/2 mL
Figure 13. Global Biciruizumab Sales Market Share by Type in 2026
Figure 14. Global Biciruizumab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Bimekizumab In Combination With Methotrexate
Figure 16. Product Picture of Bimekizumab Combined With Topical Corticosteroids
Figure 17. Global Biciruizumab Sales Market Share by Specification in 2026
Figure 18. Global Biciruizumab Revenue Market Share by Specification (2021-2026)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Retail
Figure 21. Product Picture of Online
Figure 22. Global Biciruizumab Sales Market Share by Sales Channels in 2026
Figure 23. Global Biciruizumab Revenue Market Share by Sales Channels (2021-2026)
Figure 24. Product Picture of Intravenous Injection
Figure 25. Product Picture of Subcutaneous Injection
Figure 26. Global Biciruizumab Sales Market Share by Dosage Form in 2026
Figure 27. Global Biciruizumab Revenue Market Share by Dosage Form (2021-2026)
Figure 28. Biciruizumab Consumed in Psoriasis
Figure 29. Global Biciruizumab Market: Psoriasis (2021-2026) & (Units)
Figure 30. Biciruizumab Consumed in Ankylosing Spondylitis
Figure 31. Global Biciruizumab Market: Ankylosing Spondylitis (2021-2026) & (Units)
Figure 32. Biciruizumab Consumed in Hidradenitis Suppurativa
Figure 33. Global Biciruizumab Market: Hidradenitis Suppurativa (2021-2026) & (Units)
Figure 34. Biciruizumab Consumed in Others
Figure 35. Global Biciruizumab Market: Others (2021-2026) & (Units)
Figure 36. Global Biciruizumab Sale Market Share by Application (2025)
Figure 37. Global Biciruizumab Revenue Market Share by Application in 2025
Figure 38. Biciruizumab Sales by Company in 2025 (Units)
Figure 39. Global Biciruizumab Sales Market Share by Company in 2025
Figure 40. Biciruizumab Revenue by Company in 2025 ($ millions)
Figure 41. Global Biciruizumab Revenue Market Share by Company in 2025
Figure 42. Global Biciruizumab Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Biciruizumab Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Biciruizumab Sales 2021-2026 (Units)
Figure 45. Americas Biciruizumab Revenue 2021-2026 ($ millions)
Figure 46. APAC Biciruizumab Sales 2021-2026 (Units)
Figure 47. APAC Biciruizumab Revenue 2021-2026 ($ millions)
Figure 48. Europe Biciruizumab Sales 2021-2026 (Units)
Figure 49. Europe Biciruizumab Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Biciruizumab Sales 2021-2026 (Units)
Figure 51. Middle East & Africa Biciruizumab Revenue 2021-2026 ($ millions)
Figure 52. Americas Biciruizumab Sales Market Share by Country in 2025
Figure 53. Americas Biciruizumab Revenue Market Share by Country (2021-2026)
Figure 54. Americas Biciruizumab Sales Market Share by Type (2021-2026)
Figure 55. Americas Biciruizumab Sales Market Share by Application (2021-2026)
Figure 56. United States Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Biciruizumab Sales Market Share by Region in 2025
Figure 61. APAC Biciruizumab Revenue Market Share by Region (2021-2026)
Figure 62. APAC Biciruizumab Sales Market Share by Type (2021-2026)
Figure 63. APAC Biciruizumab Sales Market Share by Application (2021-2026)
Figure 64. China Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 68. India Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Biciruizumab Sales Market Share by Country in 2025
Figure 72. Europe Biciruizumab Revenue Market Share by Country (2021-2026)
Figure 73. Europe Biciruizumab Sales Market Share by Type (2021-2026)
Figure 74. Europe Biciruizumab Sales Market Share by Application (2021-2026)
Figure 75. Germany Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 76. France Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Biciruizumab Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Biciruizumab Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Biciruizumab Sales Market Share by Application (2021-2026)
Figure 83. Egypt Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Biciruizumab Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Biciruizumab in 2026
Figure 89. Manufacturing Process Analysis of Biciruizumab
Figure 90. Industry Chain Structure of Biciruizumab
Figure 91. Channels of Distribution
Figure 92. Global Biciruizumab Sales Market Forecast by Region (2027-2032)
Figure 93. Global Biciruizumab Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Biciruizumab Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Biciruizumab Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Biciruizumab Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Biciruizumab Revenue Market Share Forecast by Application (2027-2032)
